Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1h-indole-3-carboxylic Acid, (6r,9as)-octahydro-3-oxo-2,6-methano-2h-quinolizin-8-yl Ester, Rel-, Methanesulfonate, Hydrate (1:1:1)
2. 1h-indole-3-carboxylic Acid, Octahydro-3-oxo-2,6-methano-2h-quinolizin-8-yl Ester, (2-alpha,6-alpha,8-alpha,9a-beta)-
3. 1h-indole-3-carboxylic Acid-trans-octahydro-3-oxo-2,6-methano-2h-quinolizin-8-yl Ester Methanesulfonate
4. Anzemet
5. Dolasetron
6. Dolasetron Mesilate Monohydrate
7. Dolasetron Mesylate
8. Dolasetron Mesylate Monohydrate
9. Indole-3-carboxylic Acid, Ester With (8r)-hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one
10. Mdl 73,147ef
11. Mdl 73147ef
12. Mdl-73147ef
13. Octahydro-3-oxo-2,6-methano-2h-quinolizin-8-yl 1h-indole-3-carboxylate
1. Dolasetron Mesylate
2. 878143-33-0
3. Dalasetron Mesylate Hydrate
4. Dalasetron (mesylate Hydrate)
5. 115956-13-3
6. Dolasetron Mesilate
7. Dolasetron Mesylate Monohydrate
8. Dolasetron (mesylate Hydrate)
9. Anzemet
10. Dolasetron Methanesulfonate
11. Mdl-73147ef
12. Dolasetron Mesylate Anhydrous
13. Methanesulfonic Acid;[(3s,7r)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1h-indole-3-carboxylate;hydrate
14. Ncgc00181048-01
15. Dolasetron Mesilate Monohydrate
16. Anemet
17. Dolasetronmesylate
18. Schembl1237588
19. Chembl2368924
20. Hy-b0750b
21. Hms3714b12
22. Mfcd01718979
23. Ccg-220885
24. Ccg-222446
25. Cs-3746
26. As-13228
27. D71051
28. 956d133
29. A854565
30. A916136
31. Dolasetron Mesylate Hydrate, >=98% (hplc), Powder
32. (2r,5r,6s,8r,9as)-3-oxooctahydro-2h-2,6-methanoquinolizin-8-yl 1h-indole-3-carboxylate Methanesulfonate
33. Rel-(5s,6r,8r,9as)-3-oxooctahydro-1h-2,6-methanoquinolizin-8-yl 1h-indole-3-carboxylate Methanesulfonate Hydrate
| Molecular Weight | 438.5 g/mol |
|---|---|
| Molecular Formula | C20H26N2O7S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 438.14607235 g/mol |
| Monoisotopic Mass | 438.14607235 g/mol |
| Topological Polar Surface Area | 126 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 627 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
ABOUT THIS PAGE
A Anzemet Hydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anzemet Hydrate, including repackagers and relabelers. The FDA regulates Anzemet Hydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anzemet Hydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Anzemet Hydrate supplier is an individual or a company that provides Anzemet Hydrate active pharmaceutical ingredient (API) or Anzemet Hydrate finished formulations upon request. The Anzemet Hydrate suppliers may include Anzemet Hydrate API manufacturers, exporters, distributors and traders.
Anzemet Hydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anzemet Hydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anzemet Hydrate GMP manufacturer or Anzemet Hydrate GMP API supplier for your needs.
A Anzemet Hydrate CoA (Certificate of Analysis) is a formal document that attests to Anzemet Hydrate's compliance with Anzemet Hydrate specifications and serves as a tool for batch-level quality control.
Anzemet Hydrate CoA mostly includes findings from lab analyses of a specific batch. For each Anzemet Hydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anzemet Hydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Anzemet Hydrate EP), Anzemet Hydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anzemet Hydrate USP).
LOOKING FOR A SUPPLIER?
